Abiopharma

News list

FDA updates labeling for CABERGOLINE

FDA Approval
Dec. 15, 2025, 09:50 UTC

Labeling changes approved for INGENUS PHARMS LLC. Active ingredient: CABERGOLINE. Decision date: 12/11/2025

Full text

Register to leave comments
There are no comments here yet...